After in vitro characterization and in vivo optimization with the green fluorescent protein (GFP) reporter gene, we show that CS‐g‐bPEI/pDNA NPs can effectively deliver a human insulin plasmid to reduce blood glucose levels in mice with streptozotocin (STZ)‐induced diabetes (Figure1). The gene discussed is INS; the disease is diabetes mellitus.